Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 29.3.2022TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)30222Solifenacin Teva 10 mg (tbl flm 100x10 mg (blis.PVC/PVDC/Al))30.3.2022O
 29.3.2022ratiopharm GmbH (RAT)38792Trandolapril-ratiopharm 4 mg (cps dur 98x4 mg)8.4.2022O
 29.3.2022Teva B.V. (TEV-NL-4)51645Valsartan Teva 160 mg (tbl flm 28x160 mg (blis.PVC/PE/PVDC/Al))20.4.2022R
 29.3.2022Teva B.V. (TEV-NL-4)66180Valsartan HCT Teva 160/25 mg (tbl flm 28x160 mg/25 mg (blis.PVC/PE/PVDC/Al))27.4.2022R
 29.3.2022Teva B.V. (TEV-NL-4)66199Valsartan HCT Teva 160/12,5 mg (tbl flm 98x160 mg/12,5 mg (blis.PVC/PE/PVDC/Al))27.4.2022R
 29.3.2022Actavis Group PTC ehf. (ACT-5)7558AIsotretinoin Actavis 10 mg (cps mol 30x10 mg (blis.PVC/PVDC/Al))8.4.2022O
 29.3.2022Actavis Group PTC ehf. (ACT-5)7563AIsotretinoin Actavis 20 mg (cps mol 30x20 mg (blis.PVC/PVDC/Al))8.4.2022O
 29.3.2022Sandoz GmbH (SAN-A)4594BPregabalin Sandoz 75 mg tvrdé kapsuly (cps dur 56x1x75 mg (blis.PVC/PVDC/Al-perf.))1.4.2022R
 29.3.2022Sandoz GmbH (SAN-A)91268Xorimax 250 mg (tbl obd 10x250 mg (blis. Al/Al))25.3.2022O
 29.3.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)6457AMometasone Sandoz 50 mikrogramov (aer nau 3x18 g/140 dávok (fľ.HDPE s rozpr.))1.4.2022R
 29.3.2022Sandoz Pharmaceuticals d.d. (SAN-SLO-1)96170Sumatriptan Sandoz 50 mg tablety (tbl 12x50 mg (blis.Al/Al))25.3.2022O
 29.3.2022GlaxoSmithKline Biologicals S.A. (GAG)45237Cervarix injekčná suspenzia v naplnenej injekčnej striekačke (sus inj 1x0,5 ml (striek.inj.napl.+1ihla))11.3.2022O
 29.3.2022B.Braun Melsungen AG (BME)8132AAmiped (sol inf 12x100 ml (vak.PP/styrén-etylén-butylén-styrén (SEBS)/polyéter-ester))29.3.2022R
 28.3.2022Menarini International Operations Luxembourg S.A. (MNR)75656Nebilet HCTZ 5 mg/12,5 mg (tbl flm 28x 5 mg/12,5 mg (blis. PP/COC/PP-Al))28.3.2022R
 28.3.2022Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)42283Eligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))28.3.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)